Portal de Periódicos da CAPES

Invasive Fusariosis in Nonneutropenic Patients, Spain, 2000–2015

2021; Centers for Disease Control and Prevention; Volume: 27; Issue: 1 Linguagem: Inglês

10.3201/eid2701.190782

1080-6059

Elena Pérez‐Nadales, Ana Alastruey‐Izquierdo, María José Linares-Sicilia, Juan Carlos Soto-Debrán, Edson Abdala, Julio García‐Rodríguez, Miguel Montejo, Patricia Muñóz, Miguel Salavert, Antonio Rezusta, Maite Ruiz Pérez de Pipaón, Lucrecia Yáñez, Esperanza Merino, María Isolina Campos-Herrero, José María Costa-Mateo, Jesús Fortün, Tomás García‐Lozano, Carolina García‐Vidal, Mario Fernández‐Ruiz, F Sánchez, Carmen Castro-Méndez, Inmaculada Guerrero-Lozano, Pere Soler‐Palacín, José María Aguado, Luis Martínez-Martínez, Julián Torre-Cisneros, Márcio Nucci,

Plant Pathogens and Fungal Diseases

Abstract Invasive fusariosis (IF) is associated with severe neutropenia in patients with concurrent hematologic conditions. We conducted a retrospective observational study to characterize the epidemiology of IF in 18 Spanish hospitals during 2000–2015. In that time, the frequency of IF in nonneutropenic patients increased from 0.08 cases per 100,000 admissions in 2000–2009 to 0.22 cases per 100,000 admissions in 2010–2015. Nonneutropenic IF patients often had nonhematologic conditions, such as chronic cardiac or lung disease, rheumatoid arthritis, history of solid organ transplantation, or localized fusariosis. The 90-day death rate among nonneutropenic patients (28.6%) and patients with resolved neutropenia (38.1%) was similar. However, the death rate among patients with persistent neutropenia (91.3%) was significantly higher. We used a multivariate Cox regression analysis to characterize risk factors for death: persistent neutropenia was the only risk factor for death, regardless of antifungal therapy.